NCT02654028View on ClinicalTrials.gov

Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection

NACompletedINTERVENTIONAL
Enrollment

618

Participants

Timeline

Start Date

January 5, 2019

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Liver Cancer
Interventions
PROCEDURE

Autotransfusion

These group of patients will receive autotransfusion before liver resection.

OTHER

Control group

These group of patients will not receive autotransfusion before liver resection.

Trial Locations (1)

5350032

Affiliated Tumor Hospital of Guangxi Medical University, Nanning

All Listed Sponsors
lead

Guangxi Medical University

OTHER

NCT02654028 - Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection | Biotech Hunter | Biotech Hunter